Insertional mutagenesis identifies multiple networks of cooperating genes driving intestinal tumorigenesis

Nature Genetics

Volumn 43, Issue 12, 2011, Pages 1202-1209

  March, H Nikki ^a   Rust, Alistair G ^b   Wright, Nicholas A ^c   Ten Hoeve, Jelle ^d   De Ridder, Jeroen ^d,e   Eldridge, Matthew ^a   Van Der Weyden, Louise ^b   Berns, Anton ^d   Gadiot, Jules ^d   Uren, Anthony ^d   Kemp, Richard ^a   Arends, Mark J ^f   Wessels, Lodewyk F A ^d,e   Winton, Douglas J ^a   Adams, David J ^b  

^a CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; GENE FUNCTION; GENE IDENTIFICATION; GENE INSERTION; HUMAN; MOUSE; NONHUMAN; PANETH CELL; PRIORITY JOURNAL; TRANSPOSON;

MUS;

EID: 82255179056     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.990     Document Type: Article

References (60)

1. Miller, D.G. On the nature of susceptibility to cancer. The presidential address. Cancer 46, 1307-1318 (1980). (Pubitemid 11253510)
2. Beerenwinkel, N. et al. Genetic progression and the waiting time to cancer. PLOS Comput. Biol. 3, e225 (2007).
3. Schinzel, A.C. & Hahn, W.C. Oncogenic transformation and experimental models of human cancer. Front. Biosci. 13, 71-84 (2008). (Pubitemid 351594764)
4. Kinzler, K.W. & Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87, 159-170 (1996). (Pubitemid 26358996)
5. Vogelstein, B. et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319, 525-532 (1988).
6. Rustgi, A.K. The genetics of hereditary colon cancer. Genes Dev. 21, 2525-2538 (2007). (Pubitemid 47607664)
7. Stratton, M.R., Campbell, P.J. & Futreal, P.A. The cancer genome. Nature 458, 719-724 (2009).
8. Starr, T.K. et al. A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science 323, 1747-1750 (2009).
9. Collier, L.S., Carlson, C.M., Ravimohan, S., Dupuy, A.J. & Largaespada, D.A. Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse. Nature 436, 272-276 (2005). (Pubitemid 41021279)
10. Lüchtenborg, M. et al. APC mutations in sporadic colorectal carcinomas from The Netherlands Cohort Study. Carcinogenesis 25, 1219-1226 (2004). (Pubitemid 38968050)
11. Collier, L.S. & Largaespada, D.A. Hopping around the tumor genome: transposons for cancer gene discovery. Cancer Res. 65, 9607-9610 (2005). (Pubitemid 41541432)
12. Dupuy, A.J., Akagi, K., Largaespada, D.A., Copeland, N.G. & Jenkins, N.A. Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature 436, 221-226 (2005). (Pubitemid 41021267)
13. Collier, L.S. et al. Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality. Cancer Res. 69, 8429-8437 (2009).
14. Dupuy, A.J. et al. A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice. Cancer Res. 69, 8150-8156 (2009).
15. Keng, V.W. et al. A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma. Nat. Biotechnol. 27, 264-274 (2009).
16. Moser, A.R., Pitot, H.C. & Dove, W.F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322-324 (1990).
17. Shibata, H. et al. Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 278, 120-123 (1997).
18. de Ridder, J., Uren, A., Kool, J., Reinders, M. & Wessels, L. Detecting statistically significant common insertion sites in retroviral insertional mutagenesis screens. PLOS Comput. Biol. 2, e166 (2006).
19. Uren, A.G. et al. A high-throughput splinkerette-PCR method for the isolation and sequencing of retroviral insertion sites. Nat. Protoc. 4, 789-798 (2009).
20. Segditsas, S. et al. APC and the three-hit hypothesis. Oncogene 28, 146-155 (2009).
21. Uren, A.G. et al. Large-scale mutagenesis in p19ARF-and p53-deficient mice identifies cancer genes and their collaborative networks. Cell 133, 727-741 (2008). (Pubitemid 351637624)
22. Bos, J.L. et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 327, 293-297 (1987). (Pubitemid 17075079)
23. Forrester, K., Almoguera, C., Han, K., Grizzle, W.E. & Perucho, M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327, 298-303 (1987). (Pubitemid 17075080)
24. Hung, K.E. et al. Comprehensive proteome analysis of an Apc mouse model uncovers proteins associated with intestinal tumorigenesis. Cancer Prev. Res. (Phila.) 2, 224-233 (2009).
25. Paoni, N.F., Feldman, M.W., Gutierrez, L.S., Ploplis, V.A. & Castellino, F.J. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the Apcmin/+ mouse. Physiol. Genomics 15, 228-235 (2003). (Pubitemid 38089569)
26. McAlpine, C.A., Barak, Y., Matise, I. & Cormier, R.T. Intestinal-specific PPARγ deficiency enhances tumorigenesis in Apcmin/+ mice. Int. J. Cancer 119, 2339-2346 (2006). (Pubitemid 44546953)
27. Shao, J., Washington, M.K., Saxena, R. & Sheng, H. Heterozygous disruption of the PTEN promotes intestinal neoplasia in Apcmin/+ mouse: roles of osteopontin. Carcinogenesis 28, 2476-2483 (2007). (Pubitemid 350238949)
28. Kucherlapati, M.H. et al. Loss of Rb1 in the gastrointestinal tract of Apc1638N mice promotes tumors of the cecum and proximal colon. Proc. Natl. Acad. Sci. USA 105, 15493-15498 (2008).
29. Lee, S.H. et al. ERK activation drives intestinal tumorigenesis in Apcmin/+ mice. Nat. Med. 16, 665-670 (2010).
30. Musteanu, M. et al. Stat3 is a negative regulator of intestinal tumor progression in Apcmin mice. Gastroenterology 138, 1003-1011 (2010).
31. Dopeso, H. et al. The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis. Cancer Res. 69, 7430-7438 (2009).
32. Ciznadija, D. et al. Intestinal adenoma formation and MYC activation are regulated by cooperation between MYB and Wnt signaling. Cell Death Differ. 16, 1530-1538 (2009).
33. Zeilstra, J. et al. Deletion of the WNT target and cancer stem cell marker CD44 in Apcmin/+ mice attenuates intestinal tumorigenesis. Cancer Res. 68, 3655-3661 (2008).
34. Sodir, N.M. et al. Smad3 deficiency promotes tumorigenesis in the distal colon of Apcmin/+ mice. Cancer Res. 66, 8430-8438 (2006). (Pubitemid 44449154)
35. Alberici, P. et al. Aneuploidy arises at early stages of Apc-driven intestinal tumorigenesis and pinpoints conserved chromosomal loci of allelic imbalance between mouse and human. Am. J. Pathol. 170, 377-387 (2007). (Pubitemid 47339215)
36. Knüppel, R., Dietze, P., Lehnberg, W., Frech, K. & Wingender, E. TRANSFAC retrieval program: a network model database of eukaryotic transcription regulating sequences and proteins. J. Comput. Biol. 1, 191-198 (1994).
37. Joo, M., Shahsafaei, A. & Odze, R.D. Paneth cell differentiation in colonic epithelial neoplasms: evidence for the role of the Apc/β-catenin/ Tcf pathway. Hum. Pathol. 40, 872-880 (2009).
38. Pollard, P. et al. The Apc1322T mouse develops severe polyposis associated with submaximal nuclear β-catenin expression. Gastroenterology 136, 2204-2213 (2009).
39. Simmen, F.A. et al. Dysregulation of intestinal crypt cell proliferation and villus cell migration in mice lacking Kruppel-like factor 9. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G1757-G1769 (2007). (Pubitemid 47080587)
40. Katoh, M. Cross-talk of WNT and FGF signaling pathways at GSK3β to regulate β-catenin and SNAIL signaling cascades. Cancer Biol. Ther. 5, 1059-1064 (2006). (Pubitemid 44772212)
41. Poynter, J.N. et al. Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry. Cancer Res. 67, 11128-11132 (2007). (Pubitemid 350248536)
42. Mosquera, J.M. et al. Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States. Clin. Cancer Res. 15, 4706-4711 (2009).
43. Müller, T. et al. ASAP1 promotes tumor cell motility and invasiveness, stimulates metastasis formation in vivo, and correlates with poor survival in colorectal cancer patients. Oncogene 29, 2393-2403 (2010).
44. Firestein, R. et al. CDK8 is a colorectal cancer oncogene that regulates β-catenin activity. Nature 455, 547-551 (2008).
45. Ashktorab, H. et al. Distinct genetic alterations in colorectal cancer. PLoS ONE 5, e8879 (2010).
46. Tomlinson, I. & Bodmer, W. Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nat. Med. 5, 11-12 (1999). (Pubitemid 29050986)
47. Wood, L.D. et al. The genomic landscapes of human breast and colorectal cancers. Science 318, 1108-1113 (2007). (Pubitemid 350134889)
48. Campbell, P.J. et al. Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proc. Natl. Acad. Sci. USA 105, 13081-13086 (2008).
49. Ciccarelli, F.D. The (r)evolution of cancer genetics. BMC Biol. 8, 74 (2010).
50. Joseph, S.B. & Hall, D.W. Spontaneous mutations in diploid Saccharomyces cerevisiae: more beneficial than expected. Genetics 168, 1817-1825 (2004). (Pubitemid 40066324)
51. Klein, A.M., Brash, D.E., Jones, P.H. & Simons, B.D. Stochastic fate of p53-mutant epidermal progenitor cells is tilted toward proliferation by UV B during preneoplasia. Proc. Natl. Acad. Sci. USA 107, 270-275 (2010).
52. Segditsas, S. & Tomlinson, I. Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 25, 7531-7537 (2006). (Pubitemid 44885752)
53. Suzuki, H. et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat. Genet. 36, 417-422 (2004). (Pubitemid 38437267)
54. Caldwell, G.M. et al. The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res. 64, 883-888 (2004). (Pubitemid 38176888)
55. Janssen, K.P. et al. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Gastroenterology 131, 1096-1109 (2006).
56. Albrethsen, J. et al. Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression. Mol. Cell. Proteomics 9, 988-1005 (2010).
57. Forbes, S.A. et al. COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res. 38, D652-657 (2010).
58. Su, L.K. et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256, 668-670 (1992).
59. Ireland, H. et al. Inducible Cre-mediated control of gene expression in the murine gastrointestinal tract: effect of loss of β-catenin. Gastroenterology 126, 1236-1246 (2004). (Pubitemid 38552788)
60. Ning, Z., Cox, A.J. & Mullikin, J.C. SSAHA: a fast search method for large DNA databases. Genome Res. 11, 1725-1729 (2001). (Pubitemid 33040499)